All News
NIT Rourkela develops AI-powered model to improve blood sugar predictions
The research presents a machine-learning model that enhances the accuracy of blood glucose level prediction
Read MoreAgilus Diagnostics, Lucence partner to advance cancer testing services in India
Through this collaboration, Agilus Diagnostics will integrate Lucence’s molecular testing solutions into its oncology diagnostics portfolio
Read MoreCXCR2 receptor for cancer and respiratory disease treatments visualised by IIT Kanpur researchers
Using advanced cryogenic-electron microscopy (cryo-EM), the IIT Kanpur research team has provided insight into the lock-and-key mechanism that allows CXCR2 to recognise multiple chemokines
Read MoreSTAT+: Some NIH study sections will resume reviewing grants, but final funding decisions are still in limbo
While some NIH study sections will resume, advisory council meetings, which make final funding decisions, seem to still be held up.
Read MoreSTAT+: J&J sues Samsung over a contract breach for a Stelara biosimilar
As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S.
Read MoreSome Antidepressants Linked to Faster Cognitive Decline in Dementia Patients
(MedPage Today) -- Antidepressant medications were associated with faster rates of cognitive decline in patients with dementia, a national cohort study in Sweden showed.
Read MoreBRCA1 Contribution to Prostate Cancer Called Into Question
(MedPage Today) -- Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA test results from 450 prostate cancer specimens.
Read MoreFDA Approves Adaptive Deep Brain Stimulator for Parkinson's Disease
(MedPage Today) -- The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode identifier) for people with Parkinson's disease, Medtronic annou
Read MoreGLP-1 Receptor Agonists for Diabetes Tied to Slightly Lower Depression Risk
(MedPage Today) -- In older adults with diabetes, GLP-1 receptor agonists were tied to a slightly lower risk for depression compared with one diabetes drug class but not another, a target emulation t
Read MoreNo Spike in Cardiac Arrest Among Athletes During the Pandemic, Study Says
(MedPage Today) -- Despite concerns, there was no significant increase in sudden cardiac arrest (SCA) among young athletes during the COVID-19 pandemic, according to national surveillance data.
Read More